Josh completed his BSc in Biomedical Science at Cardiff University in 2016, before being awarded a MSc in Cancer Biology and Therapeutics at Cardiff University in 2018. During his masters, Josh focused his project on the development of a nanoparticle-mediated trastuzumab delivery system to treat HER2 overexpressing breast cancers. Following this, Josh worked within a manufacturer of medical devices, specialising in oxygen therapy and assisted ventilation equipment.
Josh then undertook a PhD supervised by Prof. Martin Clift within the In Vitro Toxicology Group at Swansea University. Here, he investigated the effects of nitrogen dioxide and particulate matter air pollution within advanced in vitro models of the human airway. More recently, Josh has undertaken a postdoctoral research position where he is researching the inhalation hazard of inhaled micronanoplastics.
- Article Feed
- Joined
